Skip to main content

Specialty Pharmacy

  • NASP adds Walgreens, Pfizer and AstraZeneca execs to board

    WASHINGTON — The National Association of Specialty Pharmacy has added three new members to its board of directors. The organization brought on Walgreens VP federal government relations and U.S. public policy Ed Kaleta; Pfizer's regional president North America for rare disease Tolga Tangular; and AstraZeneca’s executive director of access services Blaine Squires. 
     
  • PhRMA adds 2 VPs

    WASHINGTON — The Pharmaceutical Research and Manufacturers of America this week announced two new additions to its ranks. The company has added Mike Hotra as VP of its public affairs team, and Ken McKay as VP state government affairs. 
     
  • FDA approves Janssen’s plaque psoriasis drug Tremfya

    SILVER SPRING, Md. — The Food and Drug Adminisration has approved Janssen Biotech’s new treatment for plaque psoriasis, the company announced Thursday. Tremfya (guselkumab) is the first drug to be approved that selectively blocks a key plaque psoriasis cytokine, the company said.

  • FDA grants full approval to Amgen’s Blincyto

    SILVER SPRING, Md. — Patients with a certain type of acute lymphoblastic leukemia have a new treatment option. The Food and Drug Administration has granted Amgen’s Blincyto (blinatumomab) full approval for the treatment of Philadelphia Chromosome-positive relaped or refractory B-cell precursor ALL.

  • Diplomat’s ThriveRx celebrates 10 years with new platforms

    CINCINNATI  — Diplomat Specialty Infusion Group’s nutrition division ThriveRx is celebrating 10 years of supporting parenteral and enteral nutrition patients with a website redesign and the rebrand of its Maximize Health program. The redesigned thriverx.diplomat.is features a new look with improved organization in an effort to improve the patient and health care professional experience on the site.

  • Walmart gets specialty pharmacy accreditation from URAC

    BENTONVILLE, Ark. — Walmart on Thursday announced that it had received specialty pharmacy accreditation from URAC. The distinction means the company has met the accreditor’s standards for demonstrated quality care, improved processes and positive patient outcomes, Walmart said. 
     
  • FDA approves new indication for Amgen’s Vectibix

    SILVER SPRING, Md. — The Food and Drug Administration has approved a new indication for Amgen’s Vectibix (panitumumab). The biologic has been approved to treat patients with wild-type RAS metastatic colorectal cancer, the company announced Thursday.

  • FDA outlines efforts to reduce orphan drug designation backlog

    SILVER SPRING, Md. — The Food and Drug Administration is committing to eliminate its orphan drug designation request backlog within 90 days and respond to all orphan drug requests within 90 days of receipt. The agency on Thursday outlined its Orphan Drug Modernization plan, which it said is part of a larger effort called the Medical Innovation Development plan modernize and make efficient the FDA’s regulatory tools and policies.

X
This ad will auto-close in 10 seconds